Showing results (41-50 of 179) with videos related to
Sort By:
Pageof 18
Danish Medical Journal|January 11, 2023
In-hospital management of type 2 diabetes in Denmark is inconsistent with international guidelinesMikkel Thor Olsen, Katrine Bagge Hansen, Carina Kirstine Klarskov, et al.Journal of Diabetes and Its Complications|July 3, 2024
Risk factors at admission of in-hospital dysglycemia, mortality, and readmissions in patients with type 2 diabetes and pneumoniaMikkel Thor Olsen, Carina Kirstine Klarskov, Katrine Bagge Hansen, et al.BMC Endocrine Disorders|July 7, 2026
Out of target glycemic control and severe hypoglycemia in older adults with diabetes presenting to the emergency departmentRune Udesen Pihl, Martha Kring Lilja, Frederik Nancke Nilsson, et al.Frontiers in Pharmacology|December 13, 2023
The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemiaSofie Broeng-Mikkelgaard, Julie Maria Bøggild Brøsen, Peter Lommer Kristensen, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 9, 2013
ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetesLouise H Færch, Anne-Sophie Sejling, Maria Lajer, et al.BMC Endocrine Disorders|May 6, 2024
Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing - a randomised controlled trialMikkel Thor Olsen, Carina Kirstine Klarskov, Ulrik Pedersen-Bjergaard, et al.The Journal of Clinical Endocrinology and Metabolism|May 15, 2018
Impact of Genetic Polymorphism in the β2-Receptor Gene on Risk of Severe Hypoglycemia in Patients With Type 1 DiabetesKim Zillo Rokamp, Niels Vidiendal Olsen, Louise Færch, et al.Diabetes, Obesity & Metabolism|January 7, 2020
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mLAthena Philis-Tsimikas, Wendy Lane, Ulrik Pedersen-Bjergaard, et al.Journal of Diabetes|May 16, 2024
Glucagon-like-peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide studyBochra Zareini, Katrine Kold Sørensen, Ulrik Pedersen-Bjergaard, et al.Pageof 18